Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
Championing Cross-Country Care at the Asia Summit on Global Health
Gleneagles is proud to mark its fifth consecutive year as the Future Private Health Partner at the Asia Summit on Global Health (ASGH).
Fortis Hospital Bengaluru Partners Teleflex to Advance Urology Innovation
Fortis Hospital Bengaluru has signed a Memorandum of Understanding with Teleflex, a global medical technology company, to set up the UroLift® Centre of Education for South Asia, the first of its kind in the region.
-(11).png?sfvrsn=660b02e5_1)
Fortis Hospital Vasant Kunj Launches Dedicated Obesity Clinic to Tackle India’s Growing Health Challenge
Fortis Hospital Vasant Kunj has taken a significant step forward in addressing India’s obesity epidemic by offering comprehensive, multidisciplinary care.
Mind Matters: Premier Integrated Labs Champions Early Alzheimer’s Detection
Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
Gleneagles JPMC Shines a Light on Unsung Heroes During Perfusion Week
At Gleneagles JPMC, where advancing cardiac health is at the heart of what we do, Perfusion Week, celebrated from 1 to 7 May, provided a meaningful opportunity to honour a group of professionals whose vital contributions often happen out of the spotlight – our perfusionists.
Advancing Clinical Research at Pantai Hospital Kuala Lumpur
With close to 70 active Industry-Sponsored Research projects, Pantai Hospital Kuala Lumpur’s strong commitment to efficient, ethical and evidenced-based research is advancing medical knowledge and improving patient outcomes.
